{
"info": {
"nct_id": "NCT01757717",
"official_title": "A Pilot Study of Image-Guided Navigation for High Dose Rate Temporary Interstitial Brachytherapy in the Palliative Management of Previously Treated Tumors of the Spine and Pelvis",
"inclusion_criteria": "* Patients must have histologic proof of a malignancy suitable for radiation therapy.\n* Patients must have received prior external beam radiation therapy to the region proposed for HDR brachytherapy treatment; evaluation of doses previously delivered to spinal cord/cauda equine, pelvis, and other critical structures (bowel, kidneys, rectum) will be taken into consideration.\n* If repeat irradiation would exceed any normal tissue constraint set by MSKCC Radiation Oncology Department dose constraint criteria, the patient will potentially be eligible.\n* If the total prior radiation dose to the cord or pelvis exceeds 100 Gy BED equivalent, the patient will be potentially eligible, where a total of 100 BED Gy equivalent is determined by the biological equivalent dose (BED) calculation; BED = nd(1 + d/α/β), where n = number of fractions and d = dose per fraction; α/β is the constant for spinal cord late effect and equals 2. [Rades 2005, Nieder 2005, Sahgal 2012]\n* KPS ≥ 60\n* Age ≥ 18 years old\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
"exclusion_criteria": "* Patients who may receive therapeutically effective doses via an external beam approach to the lesion of interest as specified by MSKCC Radiation Oncology Department dose constraint criteria.\n* Patients with kyphoplasty cement or hardware that would preclude effective catheter placement.\n* Patients with paraspinal extension of disease with visceral involvement.\n* Abnormal complete blood count. Any of the following:\n* Platelet count < 75,000/ml\n* Hb level < 9gm/dl\n* WBC < 3.5/ml\n* Abnormal coagulation profile: INR > 2.5 and/or PTT > 80\n* Patients who are on anticoagulation medication that may not be safely held for the procedure (≥ 5 days for antiplatelet agents and warfarin; ≥ 24 hours for low-molecular weight heparin formulations) will be excluded.\n* Contraindications to general anesthesia",
"miscellaneous_criteria": ""
},
"inclusion_lines": [
{
"line": "* Patients must have histologic proof of a malignancy suitable for radiation therapy.",
"criterions": [
{
"exact_snippets": [
"histologic proof of a malignancy"
],
"criterion": "malignancy",
"requirement_type": "histologic proof",
"expected_value": true
},
{
"exact_snippets": [
"suitable for radiation therapy"
],
"criterion": "malignancy",
"requirement_type": "suitability for radiation therapy",
"expected_value": true
}
]
},
{
"line": "* Patients must have received prior external beam radiation therapy to the region proposed for HDR brachytherapy treatment; evaluation of doses previously delivered to spinal cord/cauda equine, pelvis, and other critical structures (bowel, kidneys, rectum) will be taken into consideration.",
"criterions": [
{
"exact_snippets": [
"Patients must have received prior external beam radiation therapy"
],
"criterion": "external beam radiation therapy",
"requirement_type": "prior treatment",
"expected_value": true
},
{
"exact_snippets": [
"evaluation of doses previously delivered to spinal cord/cauda equine"
],
"criterion": "doses previously delivered to spinal cord/cauda equine",
"requirement_type": "evaluation",
"expected_value": "consideration"
},
{
"exact_snippets": [
"evaluation of doses previously delivered to",
"pelvis"
],
"criterion": "doses previously delivered to pelvis",
"requirement_type": "evaluation",
"expected_value": "consideration"
},
{
"exact_snippets": [
"evaluation of doses previously delivered to",
"other critical structures (bowel, kidneys, rectum)"
],
"criterion": "doses previously delivered to other critical structures",
"requirement_type": "evaluation",
"expected_value": "consideration"
}
]
},
{
"line": "* If repeat irradiation would exceed any normal tissue constraint set by MSKCC Radiation Oncology Department dose constraint criteria, the patient will potentially be eligible.",
"criterions": [
{
"exact_snippets": [
"repeat irradiation would exceed any normal tissue constraint"
],
"criterion": "normal tissue constraint",
"requirement_type": "exceedance",
"expected_value": true
},
{
"exact_snippets": [
"set by MSKCC Radiation Oncology Department dose constraint criteria"
],
"criterion": "dose constraint criteria",
"requirement_type": "source",
"expected_value": "MSKCC Radiation Oncology Department"
}
]
},
{
"line": "* If the total prior radiation dose to the cord or pelvis exceeds 100 Gy BED equivalent, the patient will be potentially eligible, where a total of 100 BED Gy equivalent is determined by the biological equivalent dose (BED) calculation; BED = nd(1 + d/α/β), where n = number of fractions and d = dose per fraction; α/β is the constant for spinal cord late effect and equals 2. [Rades 2005, Nieder 2005, Sahgal 2012]",
"criterions": [
{
"exact_snippets": [
"total prior radiation dose to the cord or pelvis"
],
"criterion": "prior radiation dose",
"requirement_type": "location",
"expected_value": [
"cord",
"pelvis"
]
},
{
"exact_snippets": [
"total prior radiation dose to the cord or pelvis exceeds 100 Gy BED equivalent"
],
"criterion": "prior radiation dose",
"requirement_type": "quantity",
"expected_value": {
"comparisons": [
{
"operator": ">",
"value": 100
}
]
}
}
]
},
{
"line": "* KPS ≥ 60",
"criterions": [
{
"exact_snippets": [
"KPS ≥ 60"
],
"criterion": "Karnofsky Performance Status (KPS)",
"requirement_type": "minimum value",
"expected_value": {
"operator": ">=",
"value": 60
}
}
]
},
{
"line": "* Age ≥ 18 years old",
"criterions": [
{
"exact_snippets": [
"Age ≥ 18 years old"
],
"criterion": "age",
"requirement_type": "N/A",
"expected_value": {
"comparisons": [
{
"operator": ">=",
"value": 18
}
]
}
}
]
},
{
"line": "Healthy volunteers allowed",
"criterions": [
{
"exact_snippets": [
"Healthy volunteers allowed"
],
"criterion": "healthy volunteers",
"requirement_type": "participation",
"expected_value": true
}
]
},
{
"line": "Must have minimum age of 18 Years",
"criterions": [
{
"exact_snippets": [
"minimum age of 18 Years"
],
"criterion": "age",
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 18
}
}
]
}
],
"exclusion_lines": [
{
"line": "* Patients who may receive therapeutically effective doses via an external beam approach to the lesion of interest as specified by MSKCC Radiation Oncology Department dose constraint criteria.",
"criterions": [
{
"exact_snippets": [
"therapeutically effective doses"
],
"criterion": "dose",
"requirement_type": "effectiveness",
"expected_value": "therapeutically effective"
},
{
"exact_snippets": [
"external beam approach"
],
"criterion": "treatment approach",
"requirement_type": "type",
"expected_value": "external beam"
},
{
"exact_snippets": [
"lesion of interest"
],
"criterion": "lesion",
"requirement_type": "interest",
"expected_value": true
},
{
"exact_snippets": [
"MSKCC Radiation Oncology Department dose constraint criteria"
],
"criterion": "dose constraint criteria",
"requirement_type": "source",
"expected_value": "MSKCC Radiation Oncology Department"
}
]
},
{
"line": "* Patients with kyphoplasty cement or hardware that would preclude effective catheter placement.",
"criterions": [
{
"exact_snippets": [
"kyphoplasty cement"
],
"criterion": "kyphoplasty cement",
"requirement_type": "presence",
"expected_value": true
},
{
"exact_snippets": [
"hardware that would preclude effective catheter placement"
],
"criterion": "hardware",
"requirement_type": "impact on catheter placement",
"expected_value": "preclude effective placement"
}
]
},
{
"line": "* Patients with paraspinal extension of disease with visceral involvement.",
"criterions": [
{
"exact_snippets": [
"paraspinal extension of disease"
],
"criterion": "paraspinal extension",
"requirement_type": "presence",
"expected_value": true
},
{
"exact_snippets": [
"visceral involvement"
],
"criterion": "visceral involvement",
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"line": "* Abnormal complete blood count. Any of the following:",
"criterions": [
{
"exact_snippets": [
"Abnormal complete blood count"
],
"criterion": "complete blood count",
"requirement_type": "normality",
"expected_value": false
}
]
},
{
"line": "* Platelet count < 75,000/ml",
"criterions": [
{
"exact_snippets": [
"Platelet count < 75,000/ml"
],
"criterion": "platelet",
"requirement_type": "count",
"expected_value": {
"comparisons": [
{
"operator": "<",
"value": 75000
}
]
}
}
]
},
{
"line": "* Hb level < 9gm/dl",
"criterions": [
{
"exact_snippets": [
"Hb level < 9gm/dl"
],
"criterion": "Hb level",
"requirement_type": "quantity",
"expected_value": {
"comparisons": [
{
"operator": "<",
"value": 9
}
]
}
}
]
},
{
"line": "* WBC < 3.5/ml",
"criterions": [
{
"exact_snippets": [
"WBC < 3.5/ml"
],
"criterion": "white blood cell",
"requirement_type": "count",
"expected_value": {
"operator": "<",
"value": 3.5
}
}
]
},
{
"line": "* Abnormal coagulation profile: INR > 2.5 and/or PTT > 80",
"criterions": [
{
"exact_snippets": [
"Abnormal coagulation profile",
"INR > 2.5"
],
"criterion": "INR",
"requirement_type": "value",
"expected_value": {
"operator": ">",
"value": 2.5
}
},
{
"exact_snippets": [
"Abnormal coagulation profile",
"PTT > 80"
],
"criterion": "PTT",
"requirement_type": "value",
"expected_value": {
"operator": ">",
"value": 80
}
}
]
},
{
"line": "* Patients who are on anticoagulation medication that may not be safely held for the procedure (≥ 5 days for antiplatelet agents and warfarin; ≥ 24 hours for low-molecular weight heparin formulations) will be excluded.",
"criterions": [
{
"exact_snippets": [
"Patients who are on anticoagulation medication"
],
"criterion": "anticoagulation medication",
"requirement_type": "usage",
"expected_value": true
},
{
"exact_snippets": [
"may not be safely held for the procedure"
],
"criterion": "anticoagulation medication",
"requirement_type": "safety of holding",
"expected_value": false
},
{
"exact_snippets": [
"≥ 5 days for antiplatelet agents"
],
"criterion": "antiplatelet agents",
"requirement_type": "holding duration",
"expected_value": {
"comparisons": [
{
"operator": ">=",
"value": 5
}
]
}
},
{
"exact_snippets": [
"≥ 5 days for",
"warfarin"
],
"criterion": "warfarin",
"requirement_type": "holding duration",
"expected_value": {
"comparisons": [
{
"operator": ">=",
"value": 5
}
]
}
},
{
"exact_snippets": [
"≥ 24 hours for low-molecular weight heparin formulations"
],
"criterion": "low-molecular weight heparin formulations",
"requirement_type": "holding duration",
"expected_value": {
"comparisons": [
{
"operator": ">=",
"value": 24
}
]
}
}
]
},
{
"line": "* Contraindications to general anesthesia",
"criterions": [
{
"exact_snippets": [
"Contraindications to general anesthesia"
],
"criterion": "general anesthesia",
"requirement_type": "contraindications",
"expected_value": true
}
]
}
],
"miscellaneous_lines": [],
"failed_inclusion": [],
"failed_exclusion": [],
"failed_miscellaneous": []
}